Lenacapavir in Short Supply Amid HIV Epidemic in Africa
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
China's HIV prevention funding of $3.49 million aims to support South Africa's young people and drug users for better health outcomes.
A pioneering public-private healthcare partnership cuts backlogs and addresses inefficiencies in surgery and patient care in KZN.
Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.
Delve into the dramatic rise of childhood hypertension and its implications for future health outcomes for young people globally.
Uncover the details of the Hetero price collusion probe as the Competition Commission examines key drug procurement allegations.